Washington, DC – Today, The Society for Assisted Reproductive Technology released its latest data on IVF and related procedures. In 2014, 375 SART member clinics performed 190,384 ART cycles and 65,175 babies were delivered using ART from SART clinics. These numbers may be adjusted as results come in from ongoing pregnancies. This is an increase from the 174,962 cycles done in 2013 and the births of 63,286 babies resulting from them.

Continuing technical refinements in ART practice support developments that make the treatment safer for mothers and babies. Elective single embryo transfer (eSET) cycles accounted for 27.2% of cycles overall in 2014 compared to 20.6% in 2013. This, along with the overall trend to transfer fewer embryos across all age groups, resulted in reduced rates of multiple births- triplets and twins.

Bradley Van Voorhis, MD, President of SART said, “The latest data reflect the success of our efforts to improve ART practice from ovarian stimulation through transfer.  We are proud of the progress we have made improving live birth rates- the true measure of a cycle’s success- and in improving maternal and child health outcomes for our patients through lower multiple birth rates.  Seventy-eight percent (78%) of births from our 2014 cycles were singletons, up from 75.5% for 2013. We continue working to increase this number.” 

Patients and physicians will note that the 2014 ART Clinic Reports and National Summary Report from SART have undergone significant changes. The reports have been completely redesigned in order to provide patients and physicians with a view of outcomes that more accurately reflects the way infertility is now treated using IVF.

As IVF practice has evolved, SART saw that ART data reporting needed to include more detail on additional procedures and encompass an extended time frame.  Procedures like embryo cryopreservation, oocyte cryopreservation, genetic testing, and single embryo transfer have both improved patients’ outcomes and affected the importance of the initial embryo transfer.  Now, with the new reporting system, outcomes will be tracked over time for individuals, accounting for fresh and frozen embryo transfers, the number and type of cycles the patient undergoes, and the best outcome- the delivery of a healthy child. Thus the new report will more accurately reflect cycle outcomes. 

The new report format includes the addition of bar graphs to enhance understanding of the relationships between patient characteristics and cycle outcomes. The reports will continue to utilize many of the features SART is known for: hover text to provide easy-access on-screen guidance for terms and metrics to aid patients in their understanding and expanded filters to allow users to dig deeper into the data. The SART Patient Predictor, found on the homepage, enables a patient to get a preliminary assessment of her chances of success with IVF based on her personal information.

While the individual Clinic Reports will be best understood by patients in the context of a consultation with their physician, the SART website will soon include an instructional video to help patients navigate their way through the new National Report and the Clinic Reports, as well.

Kevin Doody, MD, President-elect of SART observed, “As we have improved standard techniques in ART and developed new ones, fertility care has become more personalized and the interpretation of cycle data more nuanced.  This report is an important step forward which will enable doctors and patients to look at specific cycle characteristics.  Moreover, by following individual cycles for a longer time period- including secondary transfers using cryopreserved embryos or eggs, the new report represents a much more accurate way to view ART cycle success. We believe it will contribute to greater understanding of possibilities in treatment, and result in still greater improvement of outcomes in the future.”